Merck’s nearly $7 billion acquisition bolsters its cancer portfolio as blockbuster Keytruda nears patent cliff.

Direct-to-consumer TV advertising doubled the collective sales of many of the largest pharma TV advertisers across the last three years, per a recent analysis by VAB. Big Pharma’s large TV ad budgets are still paying off despite the industry-wide shift towards digital. The VAB findings highlight TV’s ability to generate brand awareness that also fuels downstream digital engagement.

Bristol Myers Squibb partners with BioNTech on new cancer drug: It’s the latest in a new class of cancer treatment drawing billions in dealmaking, which promises hope for cancer patients—but also likely higher drug prices.